Representing life as opposed to being: The bio-objectification process of the hela cells and its relation to personalized medicine

Croatian Medical Journal

Volumn 54, Issue 4, 2013, Pages 397-402

  Svalastog, Anna Lydia ^a   Martinelli, ucia ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b Museo Delle Scienze MUSE Limnology and Phycology Research Unit   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOCARCINOMA; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING THE ENTIRE ORGANISM; BIOLOGY; CAUSE OF DEATH; CELL IMMORTALIZATION; CHROMOSOME; CHROMOSOME 12; CYTOLOGY; DEGRADATION; DNA MODIFICATION; ECONOMIC ASPECT; EPIDEMIOLOGY; EXPERIMENTAL MODEL; GENOME; GENOTYPE; GYNECOLOGICAL EXAMINATION; HEALTH CARE POLICY; HELA CELL; HUMAN; INDIVIDUALITY; INDUSTRIAL PRODUCTION; INFORMED CONSENT; KNOWLEDGE; LABORATORY; LIFE; MEDICAL RESEARCH; METHODOLOGY; MOLECULAR BIOLOGY; NATIONAL HEALTH ORGANIZATION; NEOPLASM; ORGANIZATION AND MANAGEMENT; PERSONALIZED MEDICINE; PHENOMENOLOGY; PHENOTYPE; PRACTICE GUIDELINE; QUALITATIVE RESEARCH; SCIENCE; UTERINE CERVIX CARCINOMA; WELLBEING; WORLD HEALTH ORGANIZATION;

FEMALE; HELA CELLS; HUMANS; INDIVIDUALIZED MEDICINE; OBJECT ATTACHMENT; VALUE OF LIFE;

EID: 84884947423     PISSN: 03539504     EISSN: 13328166     Source Type: Journal    
DOI: 10.3325/cmj.2013.54.397     Document Type: Article

References (29)

1. Metzler I, Webster A. Bio-objects and their boundaries: governing matters at the intersection of society, politics, and science. Croat Med J. 2011;52:648-50. Medline:21990084 doi:10.3325/ cmj.2011.52.648
2. Vermeulen N, Tamminen S, Webster A, editors. Bioobjects: life in the 21st century. Farnham and Burlington: Ashgate Publishing; 2012.
3. Masters JRJ. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002;2:315-9. Medline:12001993 doi:10.1038/ nrc775
4. Landry JJ, Pyl PT, Rausch T, Zichner T, Tekkedil MM, Stutz AM, et al. The genomic and transcriptomic landscape of a HeLa cell line. G3 (Bethesda). 2013;3:1213-24. Medline:23550136 doi:10.1534/ g3.113.005777
5. Adey A, Burton JN, Kitzman JO, Hiatt JB, Lewis AP, Martin BK, et al. The haplotype-resolved genome and epigenome of the aneuploid HeLa cancer cell line. Nature. 2013;500:207-11. Medline:23925245 doi:10.1038/nature12064
6. Scherer WF, Syverton JT, Gey GO. Studies on the propagation in vitro of poliomyelitis viruses. IV. Viral multiplication in a stable strain of human malignant epithelial cells (strain HeLa) derived from an epidermoid carcinoma of the cervix. J Exp Med. 1953;97:695-710. Medline:13052828 doi:10.1084/jem.97.5.695
7. J ones HW. Records of the first physician to see Henrietta lacks at the John Hopkins Hospital: History of the beginning of the HeLa cell line. Am J Obstet Gynecol. 1997;176:S227-8. Medline:9215212 doi:10.1016/S0002-9378(97)70379-X
8. I vankovic M, Cukusic A, Gotic I, Skrobot N, Matijasic M, Polancec D, et al. Telomerase activity in HeLa cervical carcinoma cell line proliferation. Biogerontology. 2007;8:163-72. Medline:16955216 doi:10.1007/s10522-006-9043-9
9. Macville M, Schrock E, Padilla-Nash H, Keck C, Ghadimi BM, Zimonjic D, et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 1999;59:141-50. Medline:9892199
10. Sharrer T. HeLa herself. Scientist. 2006;20:22.
11. Van Valen LM, Maiorana VC. HeLa, a new microbial species. Evolutionary Theory Rev. 1991;10:71-4.
12. Skloot R. The immortal life of Henrietta Lacks. New York: Crown Publishing Books; 2010.
13. H udson KL, Collins FS. Biospecimen policy: Family matters. Nature. 2013;500:141-2. Medline:23925224 doi:10.1038/500141a
14. H olmberg T, Schwennesen N, Webster A. Bio-objects and the bioobjectification process. Croat Med J. 2011;52:740-2. Medline:22180274 doi:10.3325/cmj.2011.52.740
15. C hrupek M, Siipi H, Martinelli L. bio-objects as 'boundary crawlers': the case of microRNAs. Croat Med J. 2012;53:285-8. Medline:22661143 doi:10.3325/cmj.2012.53.285
16. Maeseele P, Allgaier J, Martinelli L. Bio-objects and the media: the role of communication in bioobjectification processes. Croat Med J. 2013;54:301-5. Medline:23771763 doi:10.3325/cmj.2013.54.301
17. O roy A, Stromskag KE, Gjengedal E. Interaction with potential donors' families: The professionals' community of concern-a phenomenological study. Int J Qual Stud Health Well-being. 2011;6. Medline:21350682
18. Svalastog AL. Making it transparent. On naming, framing and administrating biobank research on native people. N Genet Soc. 2013;32:209-42. doi:10.1080/14636778.2012.760265
19. E pstein S. Inclusion, The politics of difference in medical reseach. Chicago: The University of Chicago Press; 2007.
20. O fficial World Health Organization (WHO). The global burden of fisease 2004 updated. Available from: http://books.google.no/book s?id=xrYYZ6Jcfv0C&pg=PA12&dq=world+health+organization+on +cancer+as+main+reason+for+death&hl=en&sa=X&ei=WW efUeCI IKG34ATZhYG4Ag&ved=0CEAQ6AEwAg#v=onepage&q=world%20 health%20organization%20on%20cancer%20as%20main%20 reason%20for%20death&f=false. Accessed: August 26, 2013.
21. Svalastog AL, Gustafsson P, Jansson S. Comparative analysis of the risk-handling procedures for gene technology applications in medical and plant science. Sci Eng Ethics. 2006;12:465-79. Medline:16909149 doi:10.1007/s11948-006-0045-4
22. H ansson MG, van Ommen GJ, Chadwick R, Dillner J. Patients would benefit from simplified ethical review and consent procedure. Lancet Oncol. 2013;14:451-3. Medline:23522924 doi:10.1016/ S1470-2045(13)70129-3
23. Steinsbekk KS. Biobank Research Ethics. An examination of consent, commercial use and return of research results in the realm of population based biobanks. Trondheim: Norwegian University of Science and Technology. PhD thesis; 2013.
24. Kuhn T. The structure of scientific revolution. Chicago: Chicago University Press;1962.
25. Maeseele P, Hendrickx K, Pavone V, Van Hoyweghen I. Bio-objects' political capacity: a research agenda. Croat Med J. 2013;54:206-11. Medline:23630150 doi:10.3325/cmj.2013.54.206
26. E U. 2012/001-CO D Proposal for a regulation of the European parliament and of the council on the protection of individuals with regard to the processing of personal data and on the free movement of such data (General Data Protection Regulation). Brussels, 25.1.2012, CO M(2012) 11 final. Available from: http:// ec.europa.eu/justice/data-protection/document/review2012/ com_2012_11_en.pdf. Accessed: August 26, 2013.
27. B iobanking and Biomolecular Resource Research Infrastructure (BBMRI). Available from: http://bbmri.eu/. Accessed: August 26, 2013.
28. H ewitt RE. Biobanking: the foundation of personalized medicine. Curr Opin Oncol. 2011;23:112-9. Medline:21076300 doi:10.1097/ CCO .0b013e32834161b8
29. de Chadrieran S. Designs for life. Molecular biology after World War II. Cambridge: Cambridge University Press; 2002.